Protecting Devices Combine Energy Handling to 340 J With R25 Values to 1.5 kΩ and High Voltages to 1200 VDCMALVERN, Pa., Oct.
The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the ...
Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...
Enclosed are the copies of Newspaper advertisement of publication of the financial results of the Company for quarter and half year ended September 30th, 2024.